ViaDerma Inc (VDRM)

[excelsiorvision]

The TAM & SAM for those markets is well over $100B+ yearly and all growing 4-8%+ CAGR.

If ViaDerma can really get a move on their GTM for Vitastem online and with B2B sales globally, I don't think your PPS estimate is out of reach, it prove to be quite lower than the market will value the growing business.

VDRM's CEO has A LOT to prove still. Positive steps have been made, but this company is not going anywhere fast when it comes to sales development with the way their brand looks online. Very unprofessional for a company that supposedly has the best antibiotic in the world (or one of them).

TBD here. Staying patient and hoping bigger and better days are coming.